Company Profile

Eargo, Inc. is a medical device company. The Company is engaged in developing products to improve the quality of life of people with hearing loss. Its Eargo hearing aids are virtually invisible, rechargeable, completely in-the-canal devices indicated to compensate for mild to moderate hearing loss. Its in-the-canal devices feature quality audio, which are designed to provide up to 16 hours of battery life and feature its soft flexible medical-grade silicon tips. It is marketing various versions of hearing aids, the Eargo Max, the Eargo Neo HiFi, Eargo 5, Eargo 6 and Eargo 7. The Company markets and sells its hearing aids primarily in a direct-to-consumer format, engaging consumers through a mix of digital and traditional marketing as well as select commercial partnership, and omni-channel (including retail). Its devices are self-fitting hearing aids and are adjusted by the user to meet the user's hearing needs, without pre-programming or a hearing test from a hearing care professional.

Employees

243

Sector

Advanced Medical Equipment & Technology

More about the company

13/05/25	Eargo Launches Eargo 8 as Its Newest Hearing Aid	CI
31/03/25	Eargo and hearX Group Appoints Nic Klopper as CEO for LXE Hearing	CI
31/03/25	Eargo and hearX Group Appoints Bill Brownie as COO for LXE Hearing	CI
20/02/24	Eargo, Inc.(NasdaqGS:EAR) dropped from S&P TMI Index	CI
18/02/24	Eargo, Inc.(NasdaqGS:EAR) dropped from NASDAQ Composite Index	CI
31/01/24	Eargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness Offerings	CI
05/01/24	Twist Bioscience Names Adam Laponis Chief Financial Officer	MT
22/12/23	Eargo, Inc. Announces Chief Financial Officer Changes, Effective from January 5, 2024	CI
07/11/23	Eargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
30/10/23	Top Midday Gainers	MT
30/10/23	Wall Street Set to Open Higher Monday as Investors Parse Earnings, Await Fed Meeting	MT
29/10/23	Patient Square Capital, LP entered into an agreement to acquire remaining 23.8% stake in Eargo, Inc. for $13 million.	CI
26/10/23	Eargo Expands Relationship with Best Buy, Growing In-Store Presence to over 500 Locations	CI

09/08/22	Wells Fargo Adjusts Eargo Price Target to $2 From $10, Maintains Equal Weight Rating	MT
24/09/21	Analyst recommendations: Boohoo, Coca-Cola, Monster Beverage, Molson Coors, Philip Morris...
23/09/21	Eargo : William Blair Downgrades Eargo to Market Perform Rating From Outperform	MT
23/09/21	Eargo : JPMorgan Downgrades Eargo to Underweight From Overweight, Price Target at $11	MT
23/09/21	Eargo : Wells Fargo Downgrades Eargo to Equalweight From Overweight, Price Target at $10	MT

10/05/24	Eargo : Clinically Standard Verification and Validation of OTC Self-Fitting Hearing Aids	PU
31/01/24	Eargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness Offerings	AQ
17/01/24	Northern District Of California Grants Motion To Dismiss Amended Securities Class Action Complaint Against Hearing Aid Company	AQ
16/01/24	EARGO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Eargo, Inc. - EAR	BU
08/01/24	Twist Bioscience Appoints Adam Laponis as Chief Financial Officer	AQ

Manager	Title	Age	Since
William Brownie CEO	Chief Executive Officer	59	29/06/2023
Mark Thorpe DFI	Director of Finance/CFO	58	04/01/2024
Fred Knight CMP	Compliance Officer	-	31/07/2022

Director	Title	Age	Since
David Wu BRD	Director/Board Member	57	30/06/2014
Karr Narula BRD	Director/Board Member	46	06/12/2022
Justin Sabet-Peyman BRD	Director/Board Member	43	06/12/2022

Eargo, Inc. Share Price

Stocks

EAR

US2700872086

Advanced Medical Equipment & Technology

Latest news: Eargo, Inc.

Analysts' recommendations: Eargo, Inc.

Press Releases: Eargo, Inc.

News in other languages: Eargo, Inc.

Quotes and Performance

Managers and Directors: Eargo, Inc.

Latest insider transactions

Other Advanced Medical Equipment & Technology

Company Profile

Date	Insider	Type	Main position	Quantity	% Market Cap.
16/02/24	Karr Narula	Issuer sale	Director	10,859	0.0523%
16/02/24	Donald Spence	Issuer sale	Chairman	10,859	0.0523%
16/02/24	William Brownie	Issuer sale	Chief Executive Officer	321,786	1.5499%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
EARGO, INC.	-4.10%	-2.28%	-	-	53.39M
THERMO FISHER SCIENTIFIC, INC.	-1.72%	+3.44%	+22.84%	+56.71%	258B
DANAHER CORPORATION	-2.00%	+0.75%	+7.82%	+20.94%	163B
INTUITIVE SURGICAL, INC.	-3.73%	-4.48%	-19.14%	+64.75%	150B
BOSTON SCIENTIFIC CORPORATION	-1.66%	-8.12%	-58.32%	-17.99%	60.84B
SIEMENS HEALTHINEERS AG	-.--%	+2.46%	-11.69%	-7.41%	53.31B
EDWARDS LIFESCIENCES CORPORATION	-2.57%	+3.30%	+11.59%	+44.40%	53.03B
VEEVA SYSTEMS INC.	+0.84%	-3.12%	+7.47%	+62.40%	50.67B
AGILENT TECHNOLOGIES, INC.	-3.47%	+1.04%	+19.48%	+69.17%	49.3B
WATERS CORPORATION	-3.61%	+1.99%	+32.36%	+93.99%	45.46B
Average	-2.20%	-0.30%	+1.38%	+43.00%	98.22B
Weighted average by Cap.	-2.10%	+0.15%	+4.03%	+44.65%